On Monday, Shares of Facebook, Inc. (NASDAQ:FB), gained 2.44% to $90.10, hitting its highest level.
On Monday, Facebook’s market value closed above the $250 billion-mark, for the first time since the social networking giant went public in May 2012. In the Standard & Poor’s 500 Index, Facebook becomes the first to breach that market cap so quickly. The earlier record holder was Google, which took roughly eight years. Google now sports a market value of more than $375 billion.)
With a market value of $253 billion, Facebook is now the ninth-biggest company in the S&P 500 — bigger than Wal-Mart Stores and Procter & Gamble Co., which took decades to grow as valuable.
Facebook, Inc. operates as a social networking company worldwide. It provides a set of development tools and application programming interfaces that enable developers to integrate with Facebook to create mobile and Web applications.
Shares of Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC), skyrocketed 55.93% to $131.93, during its last trading session, hitting its highest level.
Anacor Pharmaceuticals, declared preliminary top-line results from its two Phase 3 pivotal studies of Crisaborole Topical Ointment, 2% (formerly AN2728), a novel non-steroidal topical anti-inflammatory phosphodiesterase-4 (PDE-4) inhibitor in development for the potential treatment of mild-to-moderate atopic dermatitis in children and adults. In both studies, crisaborole achieved statistically noteworthy results on all primary and secondary endpoints and demonstrated a safety profile consistent with previous studies.
Atopic dermatitis is a chronic rash characterized by inflammation and itching. Lesions of atopic dermatitis are commonly red, elevated and oozing patches and are often accompanied by pruritus (itching). The lesions’ lichenification, a thickening of the skin with exaggerated skin lines, is considered to be a hypertrophic response to chronic rubbing. Based on accessible sources, we believe about 18 to 25 million people in the United States suffer from atopic dermatitis, and 80% to 90% have mild or moderate disease. Atopic dermatitis can persist into adulthood, but most commonly appears in childhood, with estimates that between 8% and 18% of all infants and children in the United States are affected by the disease.
Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. It markets KERYDIN (tavaborole) topical solution for the treatment of onychomycosis of the toenails.
Finally, The Blackstone Group L.P. (NYSE:BX), ended its last trade with 3.28% gain, and closed at $40.91.
The Blackstone Group, declared the appointment of the Honorable William J. Burns as Senior Advisor, providing planned counsel to the firm on geopolitical issues.
Ambassador Burns is presently President of the Carnegie Endowment for International Peace, the oldest international affairs think-tank in the United States. He holds the rank of career ambassador, the highest in the U.S. Foreign Service. Before joining Carnegie, Ambassador Burns served as the Deputy Secretary of State, one of only two serving career diplomats in history to hold the title. Among his other posts during his 33-year diplomatic career, he served as Undersecretary for Political Affairs from 2008 to 2011, U.S. Ambassador to Russia from 2005 to 2008, Assistant Secretary of State for Near Eastern Affairs from 2001 to 2005, and U.S. Ambassador to Jordan from 1998 to 2001.
Ambassador Burns received a Bachelor’s degree from LaSalle University and Master’s and Doctoral degrees in international relations from Oxford University, where he studied as a Marshall Scholar. He is a recipient of four honorary Doctoral degrees and is a member of the American Academy of Arts and Sciences.
The Blackstone Group L.P. is a publicly owned investment manager. The firm also provides financial advisory services to its clients. It provides its services to public and corporate pension funds, academic, cultural, and charitable organizations.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
